PharmaTher (OTCQB: PHRRF; CSE: PHRM) is a specialty pharmaceutical company focused on developing, acquiring, and commercializing pharmaceutical products and enabling technologies.

PharmaTher manages the following assets:
  1. 3D Printing: Personalized medicines for regulated peptides and compounded pharmaceuticals;
  2. Ketamine: FDA-approved in the U.S. and ketamine microneedle patch development; and
  3. Cepharanthine: Patented enteric-coated oral cepharanthine for infectious diseases (Hantavirus).

Corporate Presentation

OTCQB: PHRRF | CSE: PHRM

Press Releases

Sign Up for Press Releases

Contact Us

PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario, M5C 1P1
​Canada
​Tel: 1-888-846-3171